Real-world effectiveness of natalizumab and fingolimod compared with injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: d6171c9d7a4f75c66bafb6e46b4c39de657c829b
First added on: Apr 30, 2026